Full Text
PIN72 Cost-Effectiveness Analysis of Palivizumab With Risk Factors for Respiratory Syncytial Virus Prevention

Abstract

Authors

M.Y. Lee E.K. Lee

Back to Volume 15, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×